文献速递血栓与止血

在SIPPET队列中使用随机肽噬菌体展示文库方法预测抑制物发生

Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort.
PubMed 文献 · Blood Adv · 2024-01-01

本研究在SIPPET队列的122例重型甲型血友病既往未治疗患者中,采用新型随机肽噬菌体展示技术绘制凝血因子VIII表位谱,并基于治疗后样本构建LASSO回归与随机森林模型预测抑制物发生,在治疗前样本中验证,C统计量分别为0.78和0.80,校准度中等良好。

要点

  • 在122例重型甲型血友病既往未治疗患者中,鉴定出27775条针对凝血因子VIII的候选肽。
  • LASSO模型预测抑制物发生的C统计量为0.78(95%CI 0.69-0.86)。
  • 随机森林模型C统计量为0.80(95%CI 0.72-0.89),两模型校准度中等良好。

核心结论

  • 基于新型随机肽噬菌体展示检测构建的两个统计模型可在暴露于外源性凝血因子VIII之前预测抑制物发生。

研究设计与样本

  • 研究纳入122例重型甲型血友病既往未治疗患者,随访至凝血因子VIII暴露50天或3年,以先发生者为准。
  • 在凝血因子VIII治疗前和治疗结束时采样,以抑制物发生为结局。
  • 采用新型随机肽噬菌体展示检测评估凝血因子VIII表位谱。
  • 在治疗后样本数据上拟合LASSO回归模型和随机森林模型,并在治疗前样本数据中验证。
  • 采用C统计量和校准图评估模型预测性能。

主要发现

  • 共鉴定出27775条针对凝血因子VIII的候选肽,作为统计模型的输入。
  • LASSO模型C统计量为0.78(95%CI 0.69-0.86),随机森林模型C统计量为0.80(95%CI 0.72-0.89)。
  • 两个模型的校准度均为中等良好。

临床怎么用

  • 作者认为这些模型可用于建立诊断检测,在开始凝血因子VIII治疗前预测抑制物发生风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inhibitor development is the most severe complication of hemophilia A (HA) care and is associated with increased morbidity and mortality. This study aimed to use a novel immunoglobulin G epitope mapping method to explore the factor VIII (FVIII)-specific epitope profile in the SIPPET cohort population and to develop an epitope mapping-based inhibitor prediction model. The population consisted of 122 previously untreated patients with severe HA who were followed up for 50 days of exposure to FVIII or 3 years, whichever occurred first. Sampling was performed before FVIII treatment and at the end of the follow-up. The outcome was inhibitor development. The FVIII epitope repertoire was assessed by means of a novel random peptide phage-display assay. A least absolute shrinkage and selection operator (LASSO) regression model and a random forest model were fitted on posttreatment sample data and validated in pretreatment sample data. The predictive performance of these models was assessed by the C-statistic and a calibration plot. We identified 27 775 peptides putatively directed against FVIII, which were used as input for the statistical models. The C-statistic of the LASSO and random forest models were good at 0.78 (95% confidence interval [CI], 0.69-0.86) and 0.80 (95% CI, 0.72-0.89). Model calibration of both models was moderately good. Two statistical models, developed on data from a novel random peptide phage display assay, were used to predict inhibitor development before exposure to exogenous FVIII. These models can be used to set up diagnostic tests that predict the risk of inhibitor development before starting treatment with FVIII.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Hassan S, Baselli G, Mollica L, et al. Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort. Blood Adv. 2024. PMID: 38593222. doi:10.1182/bloodadvances.2023011388

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。